Publication
2024
- Kreft, K. L. et al. 2024. Relevance of multiple sclerosis severity genotype in predicting disease course: A real-world cohort. Annals of Neurology 95(3), pp. 459-470. (10.1002/ana.26831)
2023
- Sheppard, J., Wynford-Thomas, R. and Robertson, N. P. 2023. “Navigating the network”: Localising the lesion with the advent of lesion network mapping. Journal of Neurology 270(12), pp. 6207-6209. (10.1007/s00415-023-12059-5)
- Daruwalla, C. et al. 2023. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal (10.1177/13524585231151951)
- Wynford-Thomas, R. and Robertson, N. P. 2023. Amyotrophic lateral sclerosis: an update on treatments from clinical trials. Journal of Neurology 270(2), pp. 1187-1189. (10.1007/s00415-022-11553-6)
2022
- Beesley, R. et al. 2022. Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviours and access to disease-modifying therapies. Multiple Sclerosis and Related Disorders 68, article number: 104121. (10.1016/j.msard.2022.104121)
- Thomas, R., Wynford-Thomas, R. and Robertson, N. P. 2022. Advances in the use of stem cell transplants in the treatment of multiple sclerosis. Journal of Neurology 269(2), pp. 1065–1067. (10.1007/s00415-021-10927-6)
2021
- Williams, S., Wynford-Thomas, R. and Robertson, N. P. 2021. Long-COVID: neurological manifestations and management. Journal of Neurology 268(12), pp. 4915–4917. (10.1007/s00415-021-10847-5)
2020
- Anderson, V. et al. 2020. Serum neurofilament-light concentration and real-world outcome in MS. Journal of the Neurological Sciences 417, article number: 117079. (10.1016/j.jns.2020.117079)
- Wynford-Thomas, R. and Robertson, N. P. 2020. Emerging treatments for neuromyelitis optica spectrum disorder. Journal of Neurology 267(9), pp. 2771-2773. (10.1007/s00415-020-10083-3)
2019
- Castle, D., Wynford-Thomas, R., Loveless, S., Bentley, E., Howell, O. W. and Tallantyre, E. C. 2019. Using biomarkers to predict clinical outcomes in multiple sclerosis. Practical Neurology 19(4), pp. 342-349. (10.1136/practneurol-2018-002000)
2017
- Wynford-Thomas, R. and Robertson, N. 2017. The economic burden of chronic neurological disease. Journal of Neurology 264(11), pp. 2345-2347. (10.1007/s00415-017-8632-7)
Articles
- Kreft, K. L. et al. 2024. Relevance of multiple sclerosis severity genotype in predicting disease course: A real-world cohort. Annals of Neurology 95(3), pp. 459-470. (10.1002/ana.26831)
- Sheppard, J., Wynford-Thomas, R. and Robertson, N. P. 2023. “Navigating the network”: Localising the lesion with the advent of lesion network mapping. Journal of Neurology 270(12), pp. 6207-6209. (10.1007/s00415-023-12059-5)
- Daruwalla, C. et al. 2023. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal (10.1177/13524585231151951)
- Wynford-Thomas, R. and Robertson, N. P. 2023. Amyotrophic lateral sclerosis: an update on treatments from clinical trials. Journal of Neurology 270(2), pp. 1187-1189. (10.1007/s00415-022-11553-6)
- Beesley, R. et al. 2022. Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviours and access to disease-modifying therapies. Multiple Sclerosis and Related Disorders 68, article number: 104121. (10.1016/j.msard.2022.104121)
- Thomas, R., Wynford-Thomas, R. and Robertson, N. P. 2022. Advances in the use of stem cell transplants in the treatment of multiple sclerosis. Journal of Neurology 269(2), pp. 1065–1067. (10.1007/s00415-021-10927-6)
- Williams, S., Wynford-Thomas, R. and Robertson, N. P. 2021. Long-COVID: neurological manifestations and management. Journal of Neurology 268(12), pp. 4915–4917. (10.1007/s00415-021-10847-5)
- Anderson, V. et al. 2020. Serum neurofilament-light concentration and real-world outcome in MS. Journal of the Neurological Sciences 417, article number: 117079. (10.1016/j.jns.2020.117079)
- Wynford-Thomas, R. and Robertson, N. P. 2020. Emerging treatments for neuromyelitis optica spectrum disorder. Journal of Neurology 267(9), pp. 2771-2773. (10.1007/s00415-020-10083-3)
- Castle, D., Wynford-Thomas, R., Loveless, S., Bentley, E., Howell, O. W. and Tallantyre, E. C. 2019. Using biomarkers to predict clinical outcomes in multiple sclerosis. Practical Neurology 19(4), pp. 342-349. (10.1136/practneurol-2018-002000)
- Wynford-Thomas, R. and Robertson, N. 2017. The economic burden of chronic neurological disease. Journal of Neurology 264(11), pp. 2345-2347. (10.1007/s00415-017-8632-7)